The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection - Trial NCT05652088
Access comprehensive clinical trial information for NCT05652088 through Pure Global AI's free database. This phase not specified trial is sponsored by Icahn School of Medicine at Mount Sinai and is currently Not yet recruiting. The study focuses on HIV Infection. Target enrollment is 8 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Icahn School of Medicine at Mount Sinai
Timeline & Enrollment
N/A
Mar 01, 2023
May 31, 2024
Primary Outcome
Change in HIV tissue viral load
Summary
The objective of this study is to understand the effects of HIV cure strategies on the virus
 and immune cells that reside within the gastrointestinal tract. Subjects receiving therapies
 with the potential for HIV cure will undergo a colonoscopy to obtain gastrointestinal tissue
 for research assays. This study will test whether receiving these therapies will induce
 changes in the immune cells in the gastrointestinal tract and reduce the tissue-associated
 HIV viral levels.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05652088
Non-Device Trial